Filana Therapeutics
FLNA
107 hedge funds and large institutions have $27.3M invested in Filana Therapeutics in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 30 reducing their positions, and 15 closing their positions.
47% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 15
28% more call options, than puts
Call options by funds: $2.58M | Put options by funds: $2.02M
4% more funds holding
Funds holding: 103 → 107 (+4)
0.03% more ownership
Funds ownership: 28.52% → 28.55% (+0.03%)
20% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 30
32% less capital invested
Capital invested by funds: $40.1M → $27.3M (-$12.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$1.5M |
| 2 |
Jane Street
New York
|
+$1.02M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$959K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$922K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$832K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$1.81M |
| 2 |
Goldman Sachs
New York
|
-$1.41M |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
-$1.31M |
| 4 |
6CM
683 Capital Management
New York
|
-$1.24M |
| 5 |
Morgan Stanley
New York
|
-$895K |
FLNA Hedge Fund Activity: Q4 2025 in Review
107 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2025, worth a combined $27.3M — down 32% from $40.1M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new FLNA positions and 15 closed out — a net gain of 7 holders — while 24 added to existing stakes and 30 trimmed.
The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $1.5M. The largest seller was JP Morgan Chase, cutting an estimated $1.81M.
- 107 institutional investors held Filana Therapeutics (FLNA) as of Q4 2025, up from 103 in Q3 2025.
- Funds reported $27.3M of Filana Therapeutics stock for Q4 2025, down 32% quarter-over-quarter.
- 22 funds opened new Filana Therapeutics positions in Q4 2025 and 15 closed out, a net change of +7 holders.
- The largest Filana Therapeutics buyer in Q4 2025 was D.E. Shaw & Co, an estimated $1.5M added.
- The largest Filana Therapeutics seller in Q4 2025 was JP Morgan Chase, an estimated $1.81M sold.
Based on aggregated 13F filings for Q4 2025.